Spenda created this circus. If they achieved what they preached...

First 540 Last

Share
Profile

Follow
PharmD

790 Posts.

203

24/06/24

21:07

Post #: 74468079
Share

Originally posted by Jacob04: ↑

I find it surprising how much time you guys spend on this forum without holding this stock. You'd think your time would be better spent looking for the next gem rather than warning new investors not to get burnt like we did. But if that’s how you choose to spend your time, then you're a better person than me.

I'm not here to add to the back and forth because, at the end of the day, most of it is just noise. I check this forum once a month, maybe twice if my bank account is hurting (like today). My knowledge of Spenda over the past 6-8 months doesn’t compare to you all since you follow it regularly and stay updated on announcements and webinars.You have four years of track record showing Adrian's tendency to overpromise. However, for the hopefuls like myself, there's no denying that some big players have shown interest, seeing potential in what this company can offer. Is Adrian the right guy for the job? Probably not if you look at his track record, but who knows—he might pull off something significant that turns this ship around quickly.

One thing we all don’t have is the Spenda badge on our shirt. While you can review the past, you can't predict the future. It’s frustrating because new investors come here and see this circus, which deters them from looking into this company further. Which kills our only hope of seeing the SP rise.

Expand

Spenda created this circus. If they achieved what they preached to everyone here there would be no circus.

SPX Price at posting: 0.7¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 305 more messages in this thread...

First 540 Last

Add SPX (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $34.59M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.7¢	$5.233K	659.1K

Buyers (Bids)

No.	Vol.	Price($)
10	7627966	0.7¢

Sellers (Offers)

Price($)	Vol.	No.
0.8¢	4085417	12

View Market Depth

No.	Vol.	Price($)
10	7627966	0.007
17	11135609	0.006
17	11370000	0.005
7	19000000	0.004
3	850001	0.003

Price($)	Vol.	No.
0.008	4085417	12
0.009	3040487	6
0.010	8626049	15
0.011	4983514	5
0.012	3671718	6

Last trade - 16.10pm 09/07/2024 (20 minute delay)

SPX (ASX) Chart

Spenda created this circus. If they achieved what they preached...

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Spenda created this circus. If they achieved what they preached...

Top Stories

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News